Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 3235-67-4
2. 1-piperidineacetic Acid
3. 2-(piperidin-1-yl)acetic Acid
4. Piperidin-1-ylacetic Acid
5. 2-piperidin-1-ylacetic Acid
6. 478920-86-4
7. Mfcd00461042
8. Piperidinoacetic Acid
9. 1-piperidineaceticacid
10. Piperidino-essigsaure
11. Piperidine Acetic Acid
12. Piperidine-acetic Acid
13. 2-piperidinoacetic Acid
14. Pperdn-1-yl-acetc Acd
15. Piperidin1-yl-acetic Acid
16. Schembl15150
17. (piperidine-1-yl)-acetic Acid
18. Chembl1624513
19. Dtxsid90276797
20. 2-(piperidin-1-yl) Acetic Acid
21. 1-pyridineacetic Acid, Hexahydro-
22. Hms1686c04
23. Zinc529593
24. Albb-000109
25. Amy20084
26. Bbl013220
27. Stk397093
28. Akos000113608
29. Ab06105
30. Ac-2876
31. Sb36588
32. Piperidin-1-yl-acetic Acid, Aldrichcpr
33. Ncgc00245101-01
34. As-31301
35. Bas 00391520
36. Sy003212
37. Db-013312
38. Db-027448
39. Bb 0219055
40. Cs-0067848
41. Ft-0677949
42. Ft-0691157
43. A821239
44. J-523966
| Molecular Weight | 143.18 g/mol |
|---|---|
| Molecular Formula | C7H13NO2 |
| XLogP3 | -2.5 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 2 |
| Exact Mass | 143.094628657 g/mol |
| Monoisotopic Mass | 143.094628657 g/mol |
| Topological Polar Surface Area | 40.5 Ų |
| Heavy Atom Count | 10 |
| Formal Charge | 0 |
| Complexity | 119 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Piperidin-1-Yl-Acetic Acid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Piperidin-1-Yl-Acetic Acid, including repackagers and relabelers. The FDA regulates Piperidin-1-Yl-Acetic Acid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Piperidin-1-Yl-Acetic Acid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Piperidin-1-Yl-Acetic Acid supplier is an individual or a company that provides Piperidin-1-Yl-Acetic Acid active pharmaceutical ingredient (API) or Piperidin-1-Yl-Acetic Acid finished formulations upon request. The Piperidin-1-Yl-Acetic Acid suppliers may include Piperidin-1-Yl-Acetic Acid API manufacturers, exporters, distributors and traders.
click here to find a list of Piperidin-1-Yl-Acetic Acid suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Piperidin-1-Yl-Acetic Acid Drug Master File in Japan (Piperidin-1-Yl-Acetic Acid JDMF) empowers Piperidin-1-Yl-Acetic Acid API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Piperidin-1-Yl-Acetic Acid JDMF during the approval evaluation for pharmaceutical products. At the time of Piperidin-1-Yl-Acetic Acid JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Piperidin-1-Yl-Acetic Acid suppliers with JDMF on PharmaCompass.
Piperidin-1-Yl-Acetic Acid Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Piperidin-1-Yl-Acetic Acid GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Piperidin-1-Yl-Acetic Acid GMP manufacturer or Piperidin-1-Yl-Acetic Acid GMP API supplier for your needs.
A Piperidin-1-Yl-Acetic Acid CoA (Certificate of Analysis) is a formal document that attests to Piperidin-1-Yl-Acetic Acid's compliance with Piperidin-1-Yl-Acetic Acid specifications and serves as a tool for batch-level quality control.
Piperidin-1-Yl-Acetic Acid CoA mostly includes findings from lab analyses of a specific batch. For each Piperidin-1-Yl-Acetic Acid CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Piperidin-1-Yl-Acetic Acid may be tested according to a variety of international standards, such as European Pharmacopoeia (Piperidin-1-Yl-Acetic Acid EP), Piperidin-1-Yl-Acetic Acid JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Piperidin-1-Yl-Acetic Acid USP).
LOOKING FOR A SUPPLIER?
